137 related articles for article (PubMed ID: 8353037)
1. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Baba H; Makino M; Khokhar AR; Bull JM
Br J Cancer; 1993 Sep; 68(3):469-74. PubMed ID: 8353037
[TBL] [Abstract][Full Text] [Related]
2. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
[TBL] [Abstract][Full Text] [Related]
3. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
[TBL] [Abstract][Full Text] [Related]
4. Haematological toxicity of carboplatin in rats.
Siddik ZH; Boxall FE; Harrap KR
Br J Cancer; 1987 Apr; 55(4):375-9. PubMed ID: 3555590
[TBL] [Abstract][Full Text] [Related]
5. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).
Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM
Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642
[TBL] [Abstract][Full Text] [Related]
6. Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs.
Page RL; McEntee MC; Williams PL; George SL; Price GS; Novotney CA; Hauck ML; Riviere JE; Dewhirst MW; Thrall DE
Int J Hyperthermia; 1994; 10(6):807-16. PubMed ID: 7884240
[TBL] [Abstract][Full Text] [Related]
7. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
8. A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.
Wondergem J; Bulger RE; Siddik ZH; Leygraaf JW; Strebel FR; Alonso M; Travis EL; Bull JM
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1551-6. PubMed ID: 2722594
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI; Cohen JD; Schmitt CL; Tutsch KD; Feierabend C; Arzoomanian RZ; Alberti D; d'Oleire F; Longo W; Heiss C
J Clin Oncol; 1993 Sep; 11(9):1787-94. PubMed ID: 8355046
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.
Sakaguchi Y; Makino M; Kaneko T; Stephens LC; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
Cancer Res; 1994 Apr; 54(8):2223-7. PubMed ID: 8174130
[TBL] [Abstract][Full Text] [Related]
11. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma.
Wiedemann GJ; d'Oleire F; Knop E; Eleftheriadis S; Bucsky P; Feddersen S; Klouche M; Geisler J; Mentzel M; Schmucker P
Cancer Res; 1994 Oct; 54(20):5346-50. PubMed ID: 7923163
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma.
Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM
Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125
[TBL] [Abstract][Full Text] [Related]
14. Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.
Trump DL; Grem JL; Tutsch KD; Willson JK; Simon KJ; Alberti D; Storer B; Tormey DC
J Clin Oncol; 1987 Aug; 5(8):1281-9. PubMed ID: 3040920
[TBL] [Abstract][Full Text] [Related]
15. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
[TBL] [Abstract][Full Text] [Related]
16. Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.
Kusumoto T; Maehara Y; Baba H; Takahashi I; Kusumoto H; Ohno S; Sugimachi K
Br J Cancer; 1993 Aug; 68(2):259-63. PubMed ID: 8347479
[TBL] [Abstract][Full Text] [Related]
17. Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?
Wondergem J; Siddik ZH; Strebel FR; Bull JM
Eur J Cancer; 1993; 29A(4):549-54. PubMed ID: 8435209
[TBL] [Abstract][Full Text] [Related]
18. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E
Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
[TBL] [Abstract][Full Text] [Related]
19. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats.
Toyota N; Strebel FR; Stephens LC; Rowe W; Matsuda H; Oshiro T; Jenkins GN; Bull JM
Oncol Rep; 1998; 5(5):1231-6. PubMed ID: 9683841
[TBL] [Abstract][Full Text] [Related]
20. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]